References
- Perucca E. Antiepileptic drugs: evolution of our knowledge and changes in drug trials. Epileptic Disord Int Epilepsy J Videotape. 2019;21(4):319–329.
- Abou-Khalil BW. Update on antiseizure medications 2022. Contin Minneap Minn. 2022;28(2):500–535. doi: 10.1212/CON.0000000000001104
- Wójcik K, Franciszek Kołek M, Dec-Ćwiek M, et al. Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019. Epilepsy Behav. 2023;139:109091. doi: 10.1016/j.yebeh.2023.109091
- Dörks M, Langner I, Timmer A, et al. Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs. Epilepsy Res. 2013;103(1):45–53. doi: 10.1016/j.eplepsyres.2012.06.008
- Mercadé Cerdá JM, López Gonzalez FJ, Serrano Castro P, et al. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations. Neurologia (Engl Ed). 2020;35(2):115–125. doi: 10.1016/j.nrl.2018.01.011
- McCudden CR. Quality, origins and limitations of common therapeutic drug reference intervals. Diagnosis. 2018;5(2):47–61. doi: 10.1515/dx-2018-0001
- Janković SM. Handbook of pharmacology and toxicology. 6th ed. Kragujevac Serbia: Faculty of Medical Sciences, University of Kragujevac; 2019.
- Devinsky O, Patel AD, Thiele EA, et al. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology. 2018;90(14):e1204–11. doi: 10.1212/WNL.0000000000005254
- Gilmartin CGS, Dowd Z, Parker APJ, et al. Interaction of cannabidiol with other antiseizure medications: a narrative review. Seizure. 2021;86:189–196. doi: 10.1016/j.seizure.2020.09.010
- Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1–02):9–62. doi: 10.1055/s-0043-116492
- Reife RA. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Adv Neurol. 1998;76:95–103.
- Home - electronic medicines compendium (EMC) [Internet]. [cited 2023 Mar 18]. Available from: https://www.medicines.org.uk/emc
- Marcath LA, Xi J, Hoylman EK, et al. Comparison of nine tools for screening drug-drug interactions of oral oncolytics. J Oncol Pract. 2018;14(6):e368–74. doi: 10.1200/JOP.18.00086
- Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16(4):409–431. doi: 10.1684/epd.2014.0714
- Benet LZ. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development. J Pharm Sci. 2013;102(1):34–42. doi: 10.1002/jps.23359
- Malki MA, Pearson ER. Drug–drug–gene interactions and adverse drug reactions. Pharmacogenomics J. 2020;20(3):355–366. doi: 10.1038/s41397-019-0122-0